Tomographic biomarkers differ by progression risk to late macular degeneration.
Progression to late AMD phenotypes was different for HRF and SDD. HRF increased risk of progression to FoA with or without nAMD, whereas SDD to FoA only, suggesting distinct biological pathways driving divergent disease outcomes.
Authors
- Ruth E. Hogg
- Enrico Bernardi
- Lajos Csincsik
- Martin Sebastian Zinkernagel
- Tunde Peto
- Katherine A Muldrew
- David M Wright
- Usha Chakravarthy
Institutions
- Ophthalmology Clinic (DE)
Publication Details
- Journal
- Open Access CRIS of the University of Bern
- Published
- 2026-02-24
- DOI
- https://doi.org/10.48620/95864
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00